Detalhe da pesquisa
1.
A phase 1 trial of NY-ESO-1-specific TCR-engineered T-cell therapy combined with a lymph node-targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma.
Int J Cancer
; 152(12): 2554-2566, 2023 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36727538
2.
First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors.
Cancer Immunol Immunother
; 69(4): 663-675, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31980914
3.
MAGE-A4, NY-ESO-1 and SAGE mRNA expression rates and co-expression relationships in solid tumours.
BMC Cancer
; 20(1): 606, 2020 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32600281
4.
[A Case of Extragonadal Germ Cell Tumor Treated by Induction Therapy with A Reduced Bep Regimen].
Hinyokika Kiyo
; 66(12): 449-452, 2020 Dec.
Artigo
em Japonês
| MEDLINE | ID: mdl-33435656
5.
[A Case of Poorly Differentiated Carcinoma of Unknown Primary Site with Risk of Choriocarcinoma Syndrome Effectively Treated with Reduced Bleomycin,Cisplatin ,Etoposide Combination Regimen(BEP Regimen)].
Gan To Kagaku Ryoho
; 45(4): 643-645, 2018 Apr.
Artigo
em Japonês
| MEDLINE | ID: mdl-29650822
6.
Retrospective analysis of risk factors for central nervous system metastases in operable breast cancer: effects of biologic subtype and Ki67 overexpression on survival.
Oncology
; 84(3): 135-40, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23235554
7.
Histological Assessment of Synovial Sarcoma Before and After TCR-T Cell Therapy and Cryoablation: A Case Report.
Anticancer Res
; 43(12): 5737-5748, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38030212
8.
αß-T cell receptor transduction gives superior mitochondrial function to γδ-T cells with promising persistence.
iScience
; 26(10): 107802, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37720098
9.
Ganglioside GD2 Expression Is Associated With Unfavorable Prognosis in Early Triple-negative Breast Cancer.
Anticancer Res
; 43(9): 4045-4053, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37648305
10.
Detection of high-risk patients resistant to CDK4/6 inhibitors with hormone receptor-positive HER2-negative advanced and metastatic breast cancer in Japan (KBCSG-TR-1316).
Breast Cancer
; 30(6): 943-951, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37486454
11.
Safety and Efficacy of NY-ESO-1 Antigen-Specific T-Cell Receptor Gene-Transduced T Lymphocytes in Patients with Synovial Sarcoma: A Phase I/II Clinical Trial.
Clin Cancer Res
; 29(24): 5069-5078, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37792433
12.
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition.
Breast Cancer
; 30(6): 872-884, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37804479
13.
Atezolizumab-Induced Sarcoidosis-Like Reaction in a Patient with Metastatic Breast Cancer.
Case Rep Oncol Med
; 2022: 2709062, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35127188
14.
Chimeric antigen receptor T-cell therapy targeting a MAGE A4 peptide and HLA-A*02:01 complex for unresectable advanced or recurrent solid cancer: protocol for a multi-institutional phase 1 clinical trial.
BMJ Open
; 12(11): e065109, 2022 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36375974
15.
NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome.
J Immunother Cancer
; 10(6)2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35768164
16.
CD204-positive macrophages accumulate in breast cancer tumors with high levels of infiltrating lymphocytes and programmed death ligand-1 expression.
Oncol Lett
; 21(1): 36, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33262828
17.
Risk factors for cisplatin-induced acute kidney injury: A pilot study on the usefulness of genetic variants for predicting nephrotoxicity in clinical practice.
Mol Clin Oncol
; 13(5): 58, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32953112
18.
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition.
Breast Cancer
; 27(3): 322-331, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32240526
19.
Cardiac safety of trastuzumab as adjuvant treatment for Japanese patients with early breast cancer.
Int J Clin Oncol
; 14(5): 431-5, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19856052
20.
First Case of Cytokine Release Syndrome after Nivolumab for Gastric Cancer.
Case Rep Oncol
; 12(1): 147-156, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31043953